Ocera Therapeutics, Inc. OCRX
No live quote for OCRX yet.
- Market cap
- 47.46M
- Revenue (ttm)
- 512.00K
- EPS (ttm)
- -0.967
- Shares out
- 26.51M
- P/E ratio
- -1.85
- Forward P/E
- -1.52
- Volume
- 969.37K
- Avg volume
- 601.12K
- Open
- 1.76
- Previous close
- 1.79
- Beta
- 1.37
- Analysts
- Buy
- Price target
- 6.38
No chart data for this range yet.
Key statistics
- Enterprise value
- 40.80M
- PEG ratio
- 0.00
- Price / sales
- 92.70
- Price / book
- 12.34
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -12.06M
- Total cash
- 14.35M
- Total debt
- 7.69M
- Return on equity
- -213.64%
- Short % of float
- 1.59%
- 50-day average
- 1.76
- 200-day average
- 1.25
Analyst view
Consensus: buy
Buy
Price target (mean) 6.38
- Target (low)
- 1.75
- Target (mean)
- 6.38
- Target (high)
- 11.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
OCRX Revenue — quarterly 0
OCRX Net income — quarterly -6.27M
OCRX EPS — quarterly -0.24
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2017 | H.C. Wainwright | down | Buy | Neutral |
| Jan 30, 2017 | JMP Securities | down | — | Market Perform |
| Dec 27, 2016 | H.C. Wainwright | init | — | Buy |
| Nov 3, 2016 | Aegis Capital | init | — | Buy |
| Feb 22, 2016 | Brean Capital | init | — | Buy |
| Mar 11, 2015 | Stifel Nicolaus | main | — | Buy |
About Ocera Therapeutics, Inc.
Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis, acute liver injury or failure, and in the areas of unmet medical need. The company is headquartered in Palo Alto, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- ocerainc.com
News
66 Biggest Movers From Yesterday 
Mid-Afternoon Market Update: Ocera Therapeutics Surges Following Acquisition News; IMPINJ Shares Plunge 
52 Stocks Moving In Thursday's Mid-Day Session 
Mid-Day Market Update: AAC Holdings Climbs On Earnings Beat; KEMET Shares Slide 
Mid-Morning Market Update: Markets Edge Lower; Alibaba Posts Strong September Quarter Results
Your note
Sign in to keep a note on OCRX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AGGARWAL GAURAV | Officer | Purchase | Jan 14, 2016 | 20,000 |
| BUKOFZER STAN | Officer | Disposition (Non Open Market) | Dec 10, 2017 | 0 |
| BYRNES MICHAEL | Officer | Disposition (Non Open Market) | Dec 10, 2017 | 0 |
| DERE WILLARD H | Director | Disposition (Non Open Market) | Dec 10, 2017 | 0 |
| DOMAIN ASSOCIATES | Beneficial Owner (10% or more) | Disposition (Non Open Market) | Dec 10, 2017 | 0 |
| DOMAIN PARTNERS VI, L.P. | Beneficial Owner (10% or more) | Disposition (Non Open Market) | Dec 10, 2017 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Perceptive Advisors LLC | 7.69% | 2,038,880 | 2.37M | Sep 29, 2017 |
| Vanguard Group, Inc. (The) | 2.69% | 713,169 | 827.28K | Sep 29, 2017 |
| Hikari Power Ltd | 2.55% | 676,596 | 784.85K | Sep 29, 2017 |
| VHCP Management II, LLC | 1.80% | 477,269 | 553.63K | Sep 29, 2017 |
| Commonwealth Equity Services Inc. | 0.38% | 100,000 | 116.00K | Sep 29, 2017 |
| Blackrock Inc. | 0.28% | 74,716 | 86.67K | Sep 29, 2017 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.61% | 691,250 | 794.94K | Jun 29, 2017 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.21% | 56,205 | 64.64K | Jun 29, 2017 |
| iShares Micro Cap ETF | 0.19% | 50,327 | 58.38K | Sep 29, 2017 |
| Vanguard Extended Market Index Fund | 0.18% | 48,417 | 55.68K | Jun 29, 2017 |
| Fidelity Extended Market Index Fund | 0.15% | 41,015 | 47.58K | Sep 29, 2017 |
| Valic Company I-Small Cap Fd | 0.14% | 37,800 | 41.58K | May 30, 2017 |